Novo Nordisk, Pfizer sweeten bid for Metsera
Digest more
Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...
During a press conference to announce a drug price deal for GLP-1s, President Donald Trump asked for more details about the ...
Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
Pfizer has launched a second lawsuit against Novo Nordisk over its $9 billion bid for biotech company Metsera. Pfizer accuses ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results